Targeting Vascular Impairment, Neuroinflammation, and Oxidative Stress Dynamics with Whole-Body Cryotherapy in Multiple Sclerosis Treatment

Int J Mol Sci. 2024 Mar 29;25(7):3858. doi: 10.3390/ijms25073858.

Abstract

Multiple sclerosis (MS), traditionally perceived as a neurodegenerative disease, exhibits significant vascular alternations, including blood-brain barrier (BBB) disruption, which may predispose patients to increased cardiovascular risks. This vascular dysfunction is intricately linked with the infiltration of immune cells into the central nervous system (CNS), which plays a significant role in perpetuating neuroinflammation. Additionally, oxidative stress serves not only as a byproduct of inflammatory processes but also as an active contributor to neural damage. The synthesis of these multifaceted aspects highlights the importance of understanding their cumulative impact on MS progression. This review reveals that the triad of vascular damage, chronic inflammation, and oxidative imbalance may be considered interdependent processes that exacerbate each other, underscoring the need for holistic and multi-targeted therapeutic approaches in MS management. There is a necessity for reevaluating MS treatment strategies to encompass these overlapping pathologies, offering insights for future research and potential therapeutic interventions. Whole-body cryotherapy (WBCT) emerges as one of the potential avenues for holistic MS management approaches which may alleviate the triad of MS progression factors in multiple ways.

Keywords: multiple sclerosis; neurodegeneration; neuroinflammation; oxidative stress; vascular impairment; whole-body cryotherapy.

Publication types

  • Review

MeSH terms

  • Cryotherapy
  • Humans
  • Multiple Sclerosis* / therapy
  • Neurodegenerative Diseases*
  • Neuroinflammatory Diseases
  • Oxidative Stress

Grants and funding

This research received no external funding.